According to a recent research report titled “Multiplex Biomarker Imaging Market (By Component Type: Instruments, Software, Services; By Imaging Technique: Immunohistochemistry (IHC) Assay, Fluorescent In Situ Hybridization (FISH) Assay, Tissue Microarray (TMA) Assay) – Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2032″ published by Precedence Research, the global multiplex biomarker imaging market size is projected to touch around USD 1,293.79 million by 2032 and growing at a CAGR of 11.9% over the forecast period 2023 to 2032. This comprehensive study examines various factors and their impact on the growth of the multiplex biomarker imaging market.
Key Takeaways
- North America contributed more than 41% of revenue share in 2022.
- Asia-Pacific is estimated to expand the fastest CAGR between 2023 and 2032.
- By component type, the instruments segment has held the largest market share of 42% in 2022.
- By component type, the software segment is anticipated to grow at a remarkable CAGR of 12.2% between 2023 and 2032.
- By imaging technique, the immunohistochemistry (IHC) assay segment generated over 44% of revenue share in 2022.
- By imaging technique, the tissue microarray (TMA) assay segment is expected to expand at the fastest CAGR over the projected period.
The report primarily focuses on the volume and value of the multiplex biomarker imaging market at the global, regional, and company levels. At the global level, the report analyzes historical data and future prospects to present an overview of the overall market size. Regionally, the study emphasizes key regions such as North America, Europe, the Middle East & Africa, Latin America, and others.
Furthermore, the research report provides specific segmentations based on regions (countries), companies, and all market segments. This analysis offers insights into the growth and revenue trends during the historical period of 2017 to 2032, as well as the projected period. By understanding these segments, it becomes possible to identify the significance of different factors that contribute to market growth.
Download a Free Copy of Our Latest Sample Report@ https://www.precedenceresearch.com/sample/3568
The research also highlights significant progressions in both organic and inorganic growth strategies within the global multiplex biomarker imaging market. Numerous companies are placing emphasis on new product launches, gaining product approvals, and implementing various business expansion tactics. Moreover, the report presents detailed profiles of firms operating in the multiplex biomarker imaging market, along with their respective market strategies. Additionally, the study concentrates on prominent industry participants, furnishing details such as company profiles, product offerings, financial updates, and noteworthy advancements.
Multiplex Biomarker Imaging Market Scope
| Report Coverage | Details |
| Growth Rate from 2023 to 2032 | CAGR of 11.9% |
| Market Size in 2023 | USD 470.33 Million |
| Market Size by 2032 | USD 1,293.79 Million |
| Largest Market | North America |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Segments Covered | By Component Type and By Imaging Technique |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Also read: Acrylonitrile Styrene Acrylate Market Size, Share, Report 2032
Major Key Points Covered in Report:
Executive Summary: It includes key trends of the electric vehicle fuel cell market related to products, applications, and other crucial factors. It also provides analysis of the competitive landscape and CAGR and market size of the electric vehicle fuel cell market based on production and revenue.
Production and Consumption by Region: It covers all regional markets to which the research study relates. Prices and key players in addition to production and consumption in each regional market are discussed.
Key Players: Here, the report throws light on financial ratios, pricing structure, production cost, gross profit, sales volume, revenue, and gross margin of leading and prominent companies competing in the Electric vehicle fuel cell market.
Market Segments: This part of the report discusses product, application and other segments of the electric vehicle fuel cell market based on market share, CAGR, market size, and various other factors.
Research Methodology: This section discusses the research methodology and approach used to prepare the report. It covers data triangulation, market breakdown, market size estimation, and research design and/or programs.
Market Key Players
The report incorporates company profiles of key players in the market. These profiles encompass vital information such as product portfolio, key strategies, and a comprehensive SWOT analysis for each player. Additionally, the report presents a matrix illustrating the presence of each prominent player, enabling readers to gain actionable insights. This facilitates a thoughtful assessment of the market status and aids in predicting the level of competition in the multiplex biomarker imaging market.
Multiplex Biomarker Imaging Market Players
- Thermo Fisher Scientific Inc.
- Merck KGaA
- PerkinElmer Inc.
- Illumina, Inc.
- Abcam plc
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
- Ayoxxa Biosystems GmbH
- Akoya Biosciences, Inc.
- Bio-Techne Corporation
- Fluidigm Corporation
- NanoString Technologies, Inc.
- Roche Diagnostics International Ltd.
- Olympus Corporation
- Leica Biosystems Nussloch GmbH (Danaher Corporation)
Segments Covered in the Report
By Component Type
- Instruments
- Software
- Services
By Imaging Technique
- Immunohistochemistry (IHC) Assay
- Fluorescent In Situ Hybridization (FISH) Assay
- Tissue Microarray (TMA) Assay
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
Table of Content:
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Multiplex Biomarker Imaging Market
5.1. COVID-19 Landscape: Multiplex Biomarker Imaging Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Multiplex Biomarker Imaging Market, By Component Type
8.1. Multiplex Biomarker Imaging Market, by Component Type, 2023-2032
8.1.1. Instruments
8.1.1.1. Market Revenue and Forecast (2020-2032)
8.1.2. Software
8.1.2.1. Market Revenue and Forecast (2020-2032)
8.1.3. Services
8.1.3.1. Market Revenue and Forecast (2020-2032)
Chapter 9. Global Multiplex Biomarker Imaging Market, By Imaging Technique
9.1. Multiplex Biomarker Imaging Market, by Imaging Technique, 2023-2032
9.1.1. Immunohistochemistry (IHC) Assay
9.1.1.1. Market Revenue and Forecast (2020-2032)
9.1.2. Fluorescent In Situ Hybridization (FISH) Assay
9.1.2.1. Market Revenue and Forecast (2020-2032)
9.1.3. Tissue Microarray (TMA) Assay
9.1.3.1. Market Revenue and Forecast (2020-2032)
Chapter 10. Global Multiplex Biomarker Imaging Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Component Type (2020-2032)
10.1.2. Market Revenue and Forecast, by Imaging Technique (2020-2032)
10.1.3. U.S.
10.1.3.1. Market Revenue and Forecast, by Component Type (2020-2032)
10.1.3.2. Market Revenue and Forecast, by Imaging Technique (2020-2032)
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Forecast, by Component Type (2020-2032)
10.1.4.2. Market Revenue and Forecast, by Imaging Technique (2020-2032)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Component Type (2020-2032)
10.2.2. Market Revenue and Forecast, by Imaging Technique (2020-2032)
10.2.3. UK
10.2.3.1. Market Revenue and Forecast, by Component Type (2020-2032)
10.2.3.2. Market Revenue and Forecast, by Imaging Technique (2020-2032)
10.2.4. Germany
10.2.4.1. Market Revenue and Forecast, by Component Type (2020-2032)
10.2.4.2. Market Revenue and Forecast, by Imaging Technique (2020-2032)
10.2.5. France
10.2.5.1. Market Revenue and Forecast, by Component Type (2020-2032)
10.2.5.2. Market Revenue and Forecast, by Imaging Technique (2020-2032)
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Forecast, by Component Type (2020-2032)
10.2.6.2. Market Revenue and Forecast, by Imaging Technique (2020-2032)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Component Type (2020-2032)
10.3.2. Market Revenue and Forecast, by Imaging Technique (2020-2032)
10.3.3. India
10.3.3.1. Market Revenue and Forecast, by Component Type (2020-2032)
10.3.3.2. Market Revenue and Forecast, by Imaging Technique (2020-2032)
10.3.4. China
10.3.4.1. Market Revenue and Forecast, by Component Type (2020-2032)
10.3.4.2. Market Revenue and Forecast, by Imaging Technique (2020-2032)
10.3.5. Japan
10.3.5.1. Market Revenue and Forecast, by Component Type (2020-2032)
10.3.5.2. Market Revenue and Forecast, by Imaging Technique (2020-2032)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Forecast, by Component Type (2020-2032)
10.3.6.2. Market Revenue and Forecast, by Imaging Technique (2020-2032)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Component Type (2020-2032)
10.4.2. Market Revenue and Forecast, by Imaging Technique (2020-2032)
10.4.3. GCC
10.4.3.1. Market Revenue and Forecast, by Component Type (2020-2032)
10.4.3.2. Market Revenue and Forecast, by Imaging Technique (2020-2032)
10.4.4. North Africa
10.4.4.1. Market Revenue and Forecast, by Component Type (2020-2032)
10.4.4.2. Market Revenue and Forecast, by Imaging Technique (2020-2032)
10.4.5. South Africa
10.4.5.1. Market Revenue and Forecast, by Component Type (2020-2032)
10.4.5.2. Market Revenue and Forecast, by Imaging Technique (2020-2032)
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Forecast, by Component Type (2020-2032)
10.4.6.2. Market Revenue and Forecast, by Imaging Technique (2020-2032)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Component Type (2020-2032)
10.5.2. Market Revenue and Forecast, by Imaging Technique (2020-2032)
10.5.3. Brazil
10.5.3.1. Market Revenue and Forecast, by Component Type (2020-2032)
10.5.3.2. Market Revenue and Forecast, by Imaging Technique (2020-2032)
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Forecast, by Component Type (2020-2032)
10.5.4.2. Market Revenue and Forecast, by Imaging Technique (2020-2032)
Chapter 11. Company Profiles
11.1. Thermo Fisher Scientific Inc.
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Merck KGaA
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. PerkinElmer Inc.
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Illumina, Inc.
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Abcam plc
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Agilent Technologies, Inc.
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Bio-Rad Laboratories, Inc.
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Ayoxxa Biosystems GmbH
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Akoya Biosciences, Inc.
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Bio-Techne Corporation
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
Why should you invest in this report?
This report presents a compelling investment opportunity for those interested in the global multiplex biomarker imaging market. It serves as an extensive and informative guide, offering clear insights into this niche market. By delving into the report, you will gain a comprehensive understanding of the various major application areas for multiplex biomarker imaging. Furthermore, it provides crucial information about the key regions worldwide that are expected to experience substantial growth within the forecast period of 2023-2030. Armed with this knowledge, you can strategically plan your market entry approaches.
Moreover, this report offers a deep analysis of the competitive landscape, equipping you with valuable insights into the level of competition prevalent in this highly competitive market. If you are already an established player, it will enable you to assess the strategies employed by your competitors, allowing you to stay ahead as market leaders. For newcomers entering this market, the extensive data provided in this report is invaluable, providing a solid foundation for informed decision-making.
Some of the key questions answered in this report:
- What is the size of the overall Multiplex biomarker imaging market and its segments?
- What are the key segments and sub-segments in the market?
- What are the key drivers, restraints, opportunities and challenges of the Multiplex biomarker imaging market and how they are expected to impact the market?
- What are the attractive investment opportunities within the Multiplex biomarker imaging market?
- What is the Multiplex biomarker imaging market size at the regional and country-level?
- Who are the key market players and their key competitors?
- What are the strategies for growth adopted by the key players in Multiplex biomarker imaging market?
- What are the recent trends in Multiplex biomarker imaging market? (M&A, partnerships, new product developments, expansions)?
- What are the challenges to the Multiplex biomarker imaging market growth?
- What are the key market trends impacting the growth of Multiplex biomarker imaging market?
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Web: https://www.precedenceresearch.com
Blog: https://www.pharma-geek.com
